Ty C. Akkoyun

Associate, New York

Biography

Overview

Ty Akkoyun is an associate in the Firm's Mergers and Acquisitions practice group, and is resident in the New York office.

Ty advises private equity funds, corporate clients and sovereign wealth funds in a broad range of industries on domestic and cross-border mergers and acquisitions, restructurings, joint ventures, de-SPAC transactions, private investments and corporate governance matters.

Bars and Courts
New York
Education
LLM
Northwestern Pritzker School of Law
LLB
Faculty of Law
Galatasaray University
Languages
English
French
Turkish

Experience

Cobepa SA, an independent, privately held investment company, in connection with:

  • its investment in Ned Stevens, one of the leading gutter cleaning services providers in the U.S., and Ned Stevens' acquisitions of A1 Exterminators and Go Green Lawn and Pest, and
  • its investment in Reaction Biology Corporation, an industry-leading provider of drug discovery services, as well as the financing of the transaction, and Reaction Biology Corporation's acquisition of vivoPharm LLC and Bioassay.

I Squared Capital, an independent global infrastructure investment manager, in connection with:

  • its acquisition of Priority Power Management, LLC, an independent energy management services and infrastructure consulting firm that provides energy management services and infrastructure solutions for commercial and industrial customers, and
  • its growth capital investment in RPower LLC, a distributed energy resource platform.

Qatar Investment Authority (QIA), the sovereign wealth fund of the State of Qatar, in connection with:

  • its minority investment in Kokusai Electric Corporation (Kokusai), a leading specialist manufacturer of semiconductor equipment based in Japan, and
  • its various co-investments in the U.S. along with private equity sponsors.

Elevance Health, Inc. (f/k/a Anthem, Inc.), one of the nation's largest health benefits companies, in its strategic partnership with Clayton, Dubilier & Rice (CD&R) to accelerate innovation in primary care delivery, enhance the healthcare experience and improve health outcomes.

Doha Venture Capital, the global venture capital arm of Qatar Free Zones, in its investment in and partnership with AeroFarms, a US-based Certified B Corporation and leader in indoor vertical farming.

Dogwood Energy, LLC in the sale of an undivided interest in the Dogwood Energy Facility, a 650 MW natural gas combined cycle facility located in Pleasant Hill, Missouri, to Evergy Missouri West, Inc.

Ripple Fiber, a fiber optic internet provider based in Charlotte, North Carolina, in. its partnership with Post Road Group, an alternative investment firm focused on digital infrastructure and real estate.

Lordstown Motors Corp., an electric vehicle manufacturer, in the sale of its manufacturing assets to LAS Capital, pursuant to Section 363 of the Bankruptcy Code.

Falcon's Beyond, a leading global entertainment development company, in its $1 billion merger agreement with FAST Acquisition Corp. II.

Quikrete Holdings, Inc., the largest manufacturer of packaged concrete and cement mixes in the United States and Canada, in its $2.74 billion acquisition of Forterra, Inc., a Nasdaq-listed manufacturer of water and drainage infrastructure pipe and products.*

Companion Spine and Viscogliosi Brothers, LLC, a private equity and merchant banking firm, in connection with its purchase of spinal assets from Medtronic, a global medical device company.*

AMETEK, Inc., a leading global provider of industrial technology solutions, in its acquisition of Magnetrol International, a leading provider of level and flow control solutions, and Crank Software, a leading provider of embedded graphical user interface (GUI) software and services.*

Fisk Alloy, Inc., a U.S. based manufacturer of copper alloy wires in connection with its agreement to be acquired by Thermo Technologies, an affiliate of Edify SA, a Swiss industrial holding company listed on the Euro-MTF market of the Luxembourg Stock Exchange.*

Ensysce Biosciences, Inc., a clinical-stage biotech company, in its business combination with Leisure Acquisition Corp.*

Milestone Partners, a private investment firm, in its investment in Cypress Group Holdings, Inc., a property and casualty insurance holding company.*

Milestone Partners, a private investment firm, in its investment in StrucSure Home Warranty, a provider of insurance-backed new home structural warranties.*

Champlain Capital, a private equity fund, in its acquisition of Pelton Shepherd, a privately held manufacturer of gel ice refrigerants.*

Susquehanna Private Capital, a private equity firm, in its investment in College Hunks Hauling Junk & Moving, a national moving and junk removal franchise.*

Susquehanna Growth Equity, a private equity and venture capital firm, in its Series B growth round investment in ActiveCampaign, the leader in Customer Experience Automation (CXA).*

Anthem Sports & Entertainment Corp., a global media platform, in its purchase of a majority interest in HDNet LLC, the parent company of U.S. television networks AXS TV (US) and HDNet Movies (US).*

Interpace Biosciences, Inc., a leading health care commercialization company, in connection with the acquisition of the biopharma business of Cancer Genetics, Inc. pursuant to a UCC Article 9 foreclosure sale and the related investment by Ampersand Capital Partners, a leading private equity firm in the diagnostic/biopharma sector, in convertible preferred stock of Interpace.*

Deluxe Corporation (NYSE: DLX), a leading payments and business technology company, in connection with the public debt financing related to its acquisition of First American Payment Systems.*

Adit EdTech Acquisition Corp., a special purpose acquisition company, in connection with its $276 million initial public offering on NYSE.*

Journey Group in its disposition of funeral home and cemetery businesses throughout the U.S.*

BioXcel, LLC as selling stockholder in an exercise of underwriter's overallotment option in connection with the follow-on public offering of BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company.*

*Matters noted above include those handled prior to joining White & Case.